Factors Related to Geographical Variation in the Incidence of End-stage Renal Failure: An Analysis in 5 French Regions
VIgIE
1 other identifier
observational
6,835
1 country
4
Brief Summary
The REIN registry highlights significant disparities in the incidence of end-stage renal disease (ESRD) between regions, especially in the North East of France. According to the literature, the incidence of ESRD in an area could be related to contextual factors influencing the needs for dialysis or transplantation (age structure, prevalence of risk factors, socioeconomic and morbidity levels), as well as to primary and secondary care provision (general practitioners and nephrologists) and to practice patterns in nephrology. The aims of this project are the following:
- 1.to compare the incidence of renal replacement therapy (dialysis or preemptive transplantation) for ESRD between the "départements" and the "cantons" belonging to the 5 regions of Eastern France (Alsace, Lorraine, Champagne-Ardenne, Bourgogne and Franche-Comté), while taking into account differences in population sizes and spatial patterns of the data,
- 2.to analyse the relations between incidence disparities and socioeconomic environment, geographic accessibility to primary and secondary care and medical practice patterns, after adjusting for morbidity and mortality rates (incidence of diabetes, cardiovascular mortality).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2015
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 27, 2016
CompletedFirst Posted
Study publicly available on registry
July 29, 2016
CompletedJuly 29, 2016
July 1, 2016
9 months
July 27, 2016
July 28, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Factors associated with renal replacement therapy
Analysis of the association between renal replacement therapy incidence disparities and socioeconomic environment, geographic accessibility to primary and secondary care and medical practice patterns.
Study period: 2010-2014
Study Arms (1)
First time renal replacement therapy
Patients beginning renal replacement therapy by renal dialysis or preemptive kidney transplant.
Eligibility Criteria
All person entering renal replacement therapy, either by renal dialysis or preemptive kidney transplant, between January 1st, 2010 and December 31, 2014, and residing in the study zone (5 northeastern administrative regions of France), found in the French REIN registry.
You may qualify if:
- Age 18 and older
- Resident of the 5 French administrative regions (Alsace, Bourgogne, Champagne-Ardenne, Franche-Comté, and Lorraine)
- First renal replacement therapy by renal dialysis or preemptive kidney transplant between January 1st, 2010 and December 31, 2014
- Found in the REIN registry
You may not qualify if:
- Transfer from another French administrative region
- Return to renal dialysis after graft rejection or a period without dialysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier Universitaire de Besanconlead
- Agence de La Biomédecinecollaborator
- Central Hospital, Nancy, Francecollaborator
- University Hospital, Strasbourg, Francecollaborator
- Observatoire Régional de la Santé d'Alsacecollaborator
Study Sites (4)
Centre d'Investigation Clinique, CHU de Besançon
Besançon, 25030, France
Hôpital William Morey, Néphrologie
Chalon-sur-Saône, 73121, France
CHU de Reims, Néphrologie
Reims, 51100, France
Centre d'Investigation Clinique CHU de Nancy
Vandœuvre-lès-Nancy, 54500, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elisabeth Monnet, MD, PhD
Centre d'Investigation Clinique, CHU Besançon
- PRINCIPAL INVESTIGATOR
Carole Ayav, MD
Centre d'Investigation Clinique, CHU Nancy
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2016
First Posted
July 29, 2016
Study Start
September 1, 2015
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
July 29, 2016
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will not share